BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1970829)

  • 1. Effect of difference in glucose infusion rate on quantification of hepatic glucose production.
    Sheu WH; Hollenbeck CB; Wu MS; Jaspan JB; Chen YD; Reaven GM
    J Clin Endocrinol Metab; 1990 May; 70(5):1354-60. PubMed ID: 1970829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of glipizide treatment on response to an infused glucose load in patients with NIDDM.
    Sheu WH; Jeng CY; Fuh MM; Chen YD; Reaven GM
    Diabetes Care; 1995 Dec; 18(12):1582-7. PubMed ID: 8722055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes.
    Shilo S; Sotsky M; Shamoon H
    J Clin Endocrinol Metab; 1990 Jan; 70(1):162-72. PubMed ID: 1967178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of glucocorticoids on hepatic sensitivity to insulin and glucagon in man.
    Dirlewanger M; Schneiter PH; Paquot N; Jequier E; Rey V; Tappy L
    Clin Nutr; 2000 Feb; 19(1):29-34. PubMed ID: 10700531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose turnover and recycling in diabetes secondary to total pancreatectomy: effect of glucagon infusion.
    Vigili de Kreutzenberg S; Maifreni L; Lisato G; Riccio A; Trevisan R; Tiengo A; Del Prato S
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1023-9. PubMed ID: 2180971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of hepatic glucose output by glucose in vivo.
    Müller MJ; Möring J; Seitz HJ
    Metabolism; 1988 Jan; 37(1):55-60. PubMed ID: 2892114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of somatostatin on the hepatic extraction of insulin and glucagon in the anesthetized dog.
    Ishida T; Röjdmark S; Bloom G; Chou MC; Field JB
    Endocrinology; 1980 Jan; 106(1):220-30. PubMed ID: 7349954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does glucagon increase plasma free fatty acid concentration in humans with normal glucose tolerance?
    Wu MS; Jeng CY; Hollenbeck CB; Chen YD; Jaspan J; Reaven GM
    J Clin Endocrinol Metab; 1990 Feb; 70(2):410-6. PubMed ID: 1967614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans.
    Lewis GF; Zinman B; Groenewoud Y; Vranic M; Giacca A
    Diabetes; 1996 Apr; 45(4):454-62. PubMed ID: 8603767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin does not alter insulin-mediated glucose disposal.
    Meneilly GS; Elahi D; Minaker KL; Rowe JW
    J Clin Endocrinol Metab; 1987 Aug; 65(2):364-7. PubMed ID: 2885337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic polypeptide administration improves abnormal glucose metabolism in patients with chronic pancreatitis.
    Brunicardi FC; Chaiken RL; Ryan AS; Seymour NE; Hoffmann JA; Lebovitz HE; Chance RE; Gingerich RL; Andersen DK; Elahi D
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3566-72. PubMed ID: 8855802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-independent effects of GLP-1 on canine liver glucose metabolism: duration of infusion and involvement of hepatoportal region.
    Dardevet D; Moore MC; Neal D; DiCostanzo CA; Snead W; Cherrington AD
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E75-81. PubMed ID: 15026303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impairment of noninsulin-mediated glucose disposal in the elderly.
    Meneilly GS; Elahi D; Minaker KL; Sclater AL; Rowe JW
    J Clin Endocrinol Metab; 1989 Mar; 68(3):566-71. PubMed ID: 2563735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased hepatic glucose production response to glucagon in trained subjects.
    Drouin R; Lavoie C; Bourque J; Ducros F; Poisson D; Chiasson JL
    Am J Physiol; 1998 Jan; 274(1):E23-8. PubMed ID: 9458743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose, insulin and somatostatin infusion for the determination of insulin sensitivity.
    Harano Y; Ohgaku S; Hidaka H; Haneda K; Kikkawa R; Shigeta Y; Abe H
    J Clin Endocrinol Metab; 1977 Nov; 45(5):1124-7. PubMed ID: 925138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon-like peptide-1 reduces hepatic glucose production indirectly through insulin and glucagon in humans.
    Larsson H; Holst JJ; Ahrén B
    Acta Physiol Scand; 1997 Aug; 160(4):413-22. PubMed ID: 9338524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of net hepatic substrate balance by phenacylimidazolium ions in the conscious dog.
    Pagliassotti MJ; Colburn CA; Moore MC; Neal DW; Dominianni SJ; Stephens TW; Cherrington AD
    Diabetes Res; 1993; 22(3):123-33. PubMed ID: 7915646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral and hepatic resistance to insulin and hepatic resistance to glucagon in uraemic subjects. Studies at physiologic and supraphysiologic hormone levels.
    Schmitz O
    Acta Endocrinol (Copenh); 1988 May; 118(1):125-34. PubMed ID: 2898853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of tumor-induced hypoglycemia with intraabdominal hemangiopericytoma.
    Chung J; Henry RR
    J Clin Endocrinol Metab; 1996 Mar; 81(3):919-25. PubMed ID: 8772551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mild type II diabetes markedly increases glucose cycling in the postabsorptive state and during glucose infusion irrespective of obesity.
    Efendic S; Karlander S; Vranic M
    J Clin Invest; 1988 Jun; 81(6):1953-61. PubMed ID: 3290257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.